Article Details

AstraZeneca Revenue Hurt as Demand for COVID-19 Treatments Slumps; Stock Drops

Retrieved on: 2024-02-08 19:12:54

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Revenue Hurt as Demand for COVID-19 Treatments Slumps; Stock Drops. View article details on hiswai:

Excerpt

... monoclonal antibodies (mAbs) treatments. Sales of its “Other Medicines” category slipped 33% as its Nexium acid reflux pill faced generic ...

Article found on: www.investopedia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo